2019
DOI: 10.1055/s-0039-1688422
|View full text |Cite
|
Sign up to set email alerts
|

Complications of Percutaneous Renal Biopsy

Abstract: Percutaneous renal biopsy is widely used for diagnosis, prognosis, and management of nephropathies. Complications may arise after renal biopsy, most commonly in the form of bleeding. Efforts should be taken to optimize modifiable risk factors such as hypertension, thrombocytopenia, and coagulopathy prior to the procedure. Unmodifiable risk factors such as poor renal function, gender, and underlying histologic diagnosis may be used to identify high-risk patients. Delayed presentation of bleeding complications i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
35
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(36 citation statements)
references
References 41 publications
(89 reference statements)
0
35
0
1
Order By: Relevance
“…Similarly a retrospective analysis of 1832 renal biopsies over 37 years reported infections to affect only 0.2% of the biopsied patients [ 2 ]. Other prospective and retrospective data from databases have shown similar low incidence of perinephric abscesses (0.3%) [ 3 ]. In contrast, bacteraemia was shown to be commoner when renal biopsy was performed on those with pyelonephritis, affecting 6.2% of such patients [ 4 ].…”
Section: Discussionmentioning
confidence: 71%
“…Similarly a retrospective analysis of 1832 renal biopsies over 37 years reported infections to affect only 0.2% of the biopsied patients [ 2 ]. Other prospective and retrospective data from databases have shown similar low incidence of perinephric abscesses (0.3%) [ 3 ]. In contrast, bacteraemia was shown to be commoner when renal biopsy was performed on those with pyelonephritis, affecting 6.2% of such patients [ 4 ].…”
Section: Discussionmentioning
confidence: 71%
“…Thirty-nine articles 4,8,[15][16][17] were eligible for data extraction, reporting on 19,500 kidney biopsies performed on 19,338 patients in 18 countries located in six regions of the world (Figure 1 -Prisma flow chart). These regions include Sub-J o u r n a l P r e -p r o o f Saharan Africa (5 studies); 24,[27][28][29]52 South Asia (15 studies); 15,22,23,[30][31][32][33][34][35][36][37][38][39]54,55 Middle East and North Africa (7 studies); 8,17,25,26,[40][41][42] Latin America and Caribbean (2 studies); 50,51 Europe and Central Asia (3 studies); 48,49,53 and East Asia and Pacific (7 studies). 4,16,[44][45][46][47]56 There were 5 studies from low-income countries 15,[22][23]…”
Section: General Characteristics Of Included Studiesmentioning
confidence: 99%
“…4,16,[44][45][46][47]56 There were 5 studies from low-income countries 15,[22][23][24]55 ; 18 from lower middle-income countries 8,17,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39]54 and 16 studies from upper middle-income countries. 4,16,[40][41][42][44][45][46][47][48][49][50][51][52][53]56 Based on quality assessment (with an interrater agreement of 79.4%), most studies (22/39; 56.4%) were moderate quality, 8,15,22,23,25,…”
Section: General Characteristics Of Included Studiesmentioning
confidence: 99%
See 2 more Smart Citations